Home » Healthcare » Pharmaceuticals » Allergy Immunotherapy Market

Allergy Immunotherapy Market By Allergen Type (Pollen, Dust mites, Pet dander, Mold) By Indication (Allergic Rhinitis, Allergic Asthma, Food Allergy)-Growth, Future Prospects & Competitive Analysis, 2021 – 2028

Published: | Report ID: 11980 | Report Format : PDF

Key Highlights of the Report

  • We can expect the global allergy immunotherapy market to reach USD 4,025.86 million by 2030. It is likely to have a compound annual growth rate of 8.03% between 2023 and 2030.
  • The subcutaneous immunotherapy segment holds the largest market share, which specifies that it is dominant in the allergy immunotherapy market.
  • Allergic rhinitis occupies more than 65% of the market share. That shows its high prevalence and important demand for immunotherapy treatments.
  • The hospital pharmacy segment holds the biggest share in the market. This evidently suggests that healthcare institutions play an important role in the distribution of allergy immunotherapy products.
  • Europe accounts for the biggest share in the global allergy immunotherapy market, which reflects a well-established market presence in the region.

Market Insights

Current Market Trends in Allergy Immunotherapy

Allergy immunotherapy is a treatment method that is employed for reducing the symptoms and effects of allergies. It does so by exposing the patient, slowly, to small amounts of the allergen. It is also called allergy shots or allergen immunotherapy.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

This approach improves the immune system of patients by building tolerance to the allergen with the passage of time. What this does is that it reduces not just the impact of allergic reactions, but improves the patients’ resistance towards it as well.

We conducted an in-depth research on the allergy immunotherapy market and uncovered that the discussed market has been witnessing substantial growth in the last few years as a result of various factors. These factors include an ever-increasing prevalence of allergies, advancements in treatment options, and increasing awareness among patients as well as healthcare professionals.

A key market trend we came across during our research is the rise in the prevalence of allergies globally. A lot of allergies, like allergic rhinitis, asthma, and food allergies, affect a considerable section of the global population.

As per reports from the World Allergy Organization, 30 to 40 percent of the world population is affected by allergies. This high prevalence naturally leads to a higher demand for effective and efficient treatment options. This drives the growth of the allergy immunotherapy market.

Another trend driving the market is the growing awareness among patients and healthcare professionals about the benefits of allergy immunotherapy. Increasingly, patients are seeking long-term solutions for their allergies instead of relying on symptomatic relief provided by medications.

Allergy immunotherapy an approach that is disease-modifying and paves the way for providing long-term relief. It reduces the need for prolonged or continuous medication use as well. What is more is that healthcare professionals are also giving notice to the potential of allergy immunotherapy and are recommending it as an efficient and a viable option for allergy treatment.

Advancements in treatment options also present an important and a considerable impact on the allergy immunotherapy market. In a traditional sense, subcutaneous immunotherapy has been the a highly common form of allergy immunotherapy.

Rapid and considerable advancements in technology have led to the development of sublingual immunotherapy. SLIT involves administering allergens in the form of tablets or drops under the tongue.

SLIT offers several advantages over SCIT, including convenience, reduced risk of severe adverse reactions, and improved patient compliance. As a result, SLIT has gained popularity and is expected to witness substantial growth in the coming years.

We also found that the increasing adoption of precision medicine approaches in healthcare has also impacted the allergy immunotherapy market. Precision medicine aims to tailor treatments to individual patients based on their genetic makeup, lifestyle, and environmental factors.

This approach, which is quite personalized, can enhance the effectiveness of allergy immunotherapy. This is so because it has the potential to identify the particular allergens to which an individual is allergic and customize the treatment as per the case’s unique demand.

Key Players and Competitive Landscape in the Allergy Immunotherapy Market

Here are a few key players in the allergy immunotherapy market:

ALK-Abelló A/S: ALK-Abelló is pharmaceutical company that operates worldwide and specializes in allergy immunotherapy products. The company provides a wide range of allergy immunotherapy treatments. These include subcutaneous and sublingual formulations. ALK-Abelló has a considerable presence in Europe and has been expanding its market boundaries through strategic partnerships and product development initiatives.

Stallergenes Greer: As per the latest statistics, Stallergenes Greer is a leading biopharmaceutical company. It is focused on the development and commercialization of allergy immunotherapy products. The company boasts a commendable portfolio of subcutaneous and sublingual allergy immunotherapy treatments. Stallergenes Greer has a strong presence globally and has been investing in abundance in the R&D for the introduction of innovative products in the market.

Aimmune Therapeutics: Aimmune Therapeutics is a biopharmaceutical company specializing in the development of treatments for food allergies. The company’s flagship product, AR101, is an oral immunotherapy for peanut allergy, which is quite common worldwide. Aimmune Therapeutics has gained a lot of attention for its peculiar approach to food allergy treatment. The company has been expanding its product pipeline to address other food allergies.

Allergy Immunotherapy Market

Market Overview

Market Size and Growth

Our comprehensive research showed that the global Allergy Immunotherapy Market has been experiencing a pretty steady growth over the years. Increasing prevalence of allergies, rising awareness about treatment options, and technological advancements in immunotherapy drive this growth. As per the report by Credence Research, the market stood at a net value of approx. $1.19 billion in 2020 and is expected to grow at a CAGR of around 10.7% between 2021 and 2028.

Key Treatment Methods

Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) are the two methods that can be used to administer Allergy Immunotherapy. In SCIT, allergen extracts are injected under the skin. On the other hand, SLIT involves placing allergen extracts under the tongue. Both these methods aim to desensitize the immune system to specific allergens and provide long-term relief from allergies.

Regional Market

North America has traditionally been the largest market for allergy immunotherapy due to high allergy prevalence and well-established healthcare infrastructure. Europe also holds a significant market share, driven by favorable reimbursement policies and increasing adoption of SLIT. The Asia-Pacific region is expected to witness substantial growth, attributed to the rising awareness of allergies and improving healthcare facilities.

Market Drivers

Increasing Prevalence of Allergies

The rising prevalence of allergic disorders, like allergic rhinitis, asthma, and food allergies, is an important driver of the allergy immunotherapy market. The inflating burden of these conditions worldwide has formed a significant demand for effective and efficient treatment options. This drives the adoption of immunotherapy.

Growing Awareness and Diagnosis

Increasing awareness about allergies, advancements in diagnostic techniques, and better accessibility to healthcare services have led to earlier and more accurate diagnosis of allergies. This has been a factor of contribution in the growth of the allergy immunotherapy market. This is so because patients seek long-term solutions for managing their allergic conditions.

Focus on Personalized Medicine

The slow but steady shift towards personalized medicine has had a positive impact on the allergy immunotherapy market. Immunotherapy offers a customized approach by focusing on specific allergens and tailoring treatments to individual patients. This focus on precision medicine has enhanced treatment efficacy and patient outcomes.

Technological Advancements

The rapid and continuous advancements in technology have also facilitated the development of not just innovative allergy immunotherapy products but delivery systems as well. Novel formulations, like sublingual tablets and oral drops, have ameliorated patient convenience and compliance. Also, advancements in molecular allergology and immunomodulation have introduced new areas for therapeutic interventions.

Market Restraints

Limited Reimbursement Policies

The sparse coverage and reimbursement for allergy immunotherapy treatments put up a considerable restraint to market growth. Unsuitable reimbursement policies in some regions disallow patient access to these therapies and may discourage healthcare providers from offering them.

Stringent Regulatory Requirements

The allergy immunotherapy market experiences oversight of stringent regulatory requirements. These include, but are not limited to, product approvals and safety evaluations. The arduous regulatory landscape and long approval processes can and often do, delay the introduction of new products, hindering market growth.

Availability of Alternative Treatment Options

The availability of alternative treatment options, like pharmacological therapies and over-the-counter remedial products present a challenge to the expansion of the allergy immunotherapy market. Some patients may and do opt for these alternatives for the sake of convenience, cost-effectiveness, or perceived effectiveness. This negatively impacts the adoption as well as the acceptance of immunotherapy.

Market Opportunities

Expansion in Emerging Markets

Developing markets offer quite a decent number of great opportunities for the allergy immunotherapy market. Fast urbanization, rising healthcare expenditure, and growing awareness about allergies in these regions give way to an ideal market environment. Expanding market presence in developing economies can promote revenue growth and be a source of market penetration.

Development of Novel Immunotherapies

As per the market experts we talked to while researching for this report, the introduction of novel immunotherapies, that include, but are not limited to recombinant allergens, peptide-based immunotherapy, and biologic agents, have immense potential in the allergy immunotherapy market. These innovative approaches are directly proportional to improved efficacy, reduced treatment duration, and enhanced patient safety. This results in the fostering of market growth.

Collaboration and Partnerships

Collaborations and partnerships between pharmaceutical companies, research institutions, and healthcare organizations can solidify research and development endeavors in allergy immunotherapy. Joint projects and strategic alliances clear the way for knowledge exchange, resource sharing, and expedited market entry, creating growth opportunities.

Patient Education and Awareness

Escalated patient education and awareness programs can drive the demand for allergy immunotherapy. As long as the understanding of the benefits, safety, and long-term efficacy of immunotherapy gets promoted, these initiatives can enhance patient acceptance and drive market growth.

Why to Buy This Report

As far as the market analysis in this report is concerned, it is pretty comprehensive. It offers a detailed analysis of the global allergy immunotherapy market that includes market size, growth rate, and key market segments. It covers the prevailing trends within the discussed market along with market drivers, restraints, and opportunities. This not only makes the readers aware of the current market state, but provides a comprehensive understanding of the market dynamics as well.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The report offers deep insights into the allergy immunotherapy market. In this report, you will find an analysis of market trends, market dynamics, and the regulatory landscape. It not only explores the factors influencing market growth but provides valuable information on the competitive landscape and key market players as well. By reading this piece, you can gain a comprehensive understanding of the market environment and its evolving nature.

The report segments the market based on immunotherapy type, application, end-user, and geography. This segmentation helps readers to identify the key growth areas and make strategic business decisions. It provides a clear picture of the market landscape and enables readers to target specific market segments.

The report profiles the key players in the allergy immunotherapy market and analyzes their product portfolios, market strategies, and recent developments. It provides insights into the competitive dynamics and market positioning of these players. This information is valuable for companies looking to enter the market or strengthen their market presence.

The report is prepared by industry experts and analysts who have conducted extensive research and analysis. The information provided is reliable, credible, and up-to-date. It helps readers to stay ahead in the competitive market landscape.

By purchasing this report, readers can save significant time and effort in gathering market information and conducting their own research. The report provides comprehensive insights and analysis, saving valuable resources.

CHAPTER NO. 1 : INTRODUCTION 15
1.1. Report Description 15
1.1.1. Purpose of the Report 15
1.1.2. USP & Key Offerings 15
1.2. Key Benefits for Stakeholders 15
1.3. Target Audience 16
1.4. Report Scope 16

CHAPTER NO. 2 : EXECUTIVE SUMMARY 20
2.1. Allergy Immunotherapy Market Snapshot 20
2.2. Global Allergy Immunotherapy Market, 2017 – 2030 (USD Million) 22
2.1. Insights from Primary Respondents 22

CHAPTER NO. 3 : COVID 19 IMPACT ANALYSIS 23
3.1. Impact Assessment of COVID-19 Pandemic, By Region 23

CHAPTER NO. 4 : ALLERGY IMMUNOTHERAPY MARKET – INDUSTRY ANALYSIS 24
4.1. Introduction 24
4.2. Market Drivers 25
4.2.1. Increasing Prevalence of Allergies 25
4.2.2. Growing Awareness and Diagnosis 26
4.3. Market Restraints 26
4.3.1. Restraining Factor Analysis 26
4.4. Market Opportunities 27
4.4.1. Market Opportunity Analysis 27
4.5. Porter’s Five Forces Analysis 27
4.6. Value Chain Analysis 28

CHAPTER NO. 5 : KEY INVESTMENT POCKETS ANALYSIS 29
5.1. Top Investment Pockets 29
5.1.1.1. Allergy Immunotherapy Market Attractiveness Analysis, By Allergen Type 29
5.1.1.2. Allergy Immunotherapy Market Attractiveness Analysis, By Indication 29
5.1.1.3. Allergy Immunotherapy Market Attractiveness Analysis, By Treatment 30
5.1.1.4. Allergy Immunotherapy Market Attractiveness Analysis, By Distribution Channel 30
5.2. Product Life Cycle Analysis 31
5.3. Incremental Revenue Growth Opportunity, 2023 – 2030 32
5.3.1. Allergen Type 32
5.3.2. Indication 32
5.3.3. Treatment 33
5.3.4. Distribution Channel 33

CHAPTER NO. 6 : MARKET POSITIONING OF KEY PLAYERS 34
6.1. Company Market Share Analysis –2020 and 2022 34
6.1.1. Global Allergy Immunotherapy Market: Company Market Share, 2022 34
6.1.2. Global Allergy Immunotherapy Market: Company Market Share, 2022 34
6.1. Global Allergy Immunotherapy Market Company Volume Market Share, 2022 35
6.2. Global Allergy Immunotherapy Market Company Revenue Market Share, 2022 36
6.3. Market Position of Key Players 2022 37
6.3.1. Market Position of Key Players, 2022 37
6.4. Strategic Developments 38
6.4.1. Acquisitions & Mergers 38
6.4.2. New Product Launch 38
6.4.3. Regional Expansion 38

CHAPTER NO. 7 : ALLERGY IMMUNOTHERAPY MARKET – BY ALLERGEN TYPE SEGMENT ANALYSIS 39
7.1. Allergy Immunotherapy Market Overview, by Allergen Type Segment 39
7.1.1. Global Allergy Immunotherapy Market Revenue Share, By Allergen Type, 2022 & 2030 40
7.2. Pollen 41
7.2.1. Global Pollen Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 41
7.3. Dust mites 42
7.3.1. Global Pollen Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 42
7.4. Pet dander 43
7.4.1. Global Pet dander Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 43
7.5. Mold 44
7.5.1. Global Mold Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 44
7.6. Others 45
7.6.1. Global Others Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 45

CHAPTER NO. 8 : ALLERGY IMMUNOTHERAPY MARKET – BY INDICATION SEGMENT ANALYSIS 46
8.1. Allergy Immunotherapy Market Overview, by Indication Segment 46
8.1.1. Global Allergy Immunotherapy Market Revenue Share, By Indication, 2022 & 2030 47
8.2. Allergic Rhinitis 48
8.2.1. Global Allergy Immunotherapy for Allergic Rhinitis Market Revenue, By Region, 2017 – 2022 (USD Million) 48
8.3. Allergic Asthma 49
8.3.1. Global Allergy Immunotherapy for Allergic Asthma Market Revenue, By Region, 2017 – 2022 (USD Million) 49
8.4. Food Allergy 50
8.4.1. Global Allergy Immunotherapy for Food Allergy Market Revenue, By Region, 2017 – 2022 (USD Million) 50
8.5. Atopic Dermatitis 51
8.5.1. Global Allergy Immunotherapy for Atopic Dermatitis Market Revenue, By Region, 2017 – 2022 (USD Million) 51
8.6. Others 52
8.6.1. Global Allergy Immunotherapy for Others Market Revenue, By Region, 2017 – 2022 (USD Million) 52

CHAPTER NO. 9 : ALLERGY IMMUNOTHERAPY MARKET – BY TREATMENT SEGMENT ANALYSIS 53
9.1. Allergy Immunotherapy Market Overview, by Treatment Segment 53
9.1.1. Global Allergy Immunotherapy Market Revenue Share, By Treatment, 2022 & 2030 54
9.2. Subcutaneous immunotherapy (SCIT) 55
9.2.1. Global Subcutaneous immunotherapy (SCIT) Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 55
9.3. Sublingual immunotherapy (SLIT) 56
9.3.1. Global Sublingual immunotherapy (SLIT) Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 56
9.4. Oral immunotherapy (OIT) 57
9.4.1. Global Oral immunotherapy (OIT) Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 57

CHAPTER NO. 10 : ALLERGY IMMUNOTHERAPY MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 60
10.1. Allergy Immunotherapy Market Overview, by Distribution Channel Segment 60
10.1.1. Global Allergy Immunotherapy Market Revenue Share, By Distribution Channel, 2022 & 2030 61
10.2. Hospitals 62
10.2.1. Global Hospitals Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 62
10.3. Clinics 63
10.3.1. Global Clinics Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 63
10.4. Pharmacies 64
10.4.1. Global Pharmacies Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 64

CHAPTER NO. 11 : ALLERGY IMMUNOTHERAPY MARKET – REGIONAL ANALYSIS 67
11.1. Allergy Immunotherapy Market Overview, by Region Segment 67
11.1.1. Global Allergy Immunotherapy Market Revenue Share, By Region, 2022 & 2030 68
11.1.2. Global Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 69
11.1.3. Global Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 70
11.1.4. Global Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 71
11.1.5. Global Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 72
11.1.6. Global Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 73
11.2. North America 74
11.2.1. North America Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 75
11.2.2. North America Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 76
11.2.3. North America Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 77
11.2.4. North America Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 78
11.2.5. North America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 79
11.2.6. U.S. 80
11.2.7. Canada 80
11.2.8. Mexico 80
11.3. Europe 81
11.3.1. Europe Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 82
11.3.2. Europe Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 83
11.3.3. Europe Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 84
11.3.4. Europe Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 85
11.3.5. Europe Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 86
11.3.6. UK 87
11.3.7. France 87
11.3.8. Germany 87
11.3.9. Italy 87
11.3.10. Spain 87
11.3.11. Russia 87
11.3.12. BENELUX 87
11.3.13. Sweden 87
11.3.14. Denmark 87
11.3.15. Poland 87
11.3.16. Austria 87
11.3.17. Rest of Europe 87
11.4. Asia Pacific 88
11.4.1. Asia Pacific Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 89
11.4.2. Asia Pacific Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 90
11.4.3. Asia Pacific Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 91
11.4.4. Asia Pacific Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 92
11.4.5. Asia Pacific Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 93
11.4.6. China 94
11.4.7. Japan 94
11.4.8. South Korea 94
11.4.9. India 94
11.4.10. Thailand 94
11.4.11. Indonesia 94
11.4.12. Vietnam 94
11.4.13. Malaysia 94
11.4.14. Philippines 94
11.4.15. Taiwan 94
11.4.16. Rest of Asia Pacific 94
11.5. Latin America 95
11.5.1. Latin America Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 96
11.5.2. Latin America Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 97
11.5.3. Latin America Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 98
11.5.4. Latin America Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 99
11.5.5. Latin America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 100
11.5.6. Brazil 101
11.5.7. Argentina 101
11.5.8. Colombia 101
11.5.9. Chile 101
11.5.10. Peru 101
11.5.11. Rest of Latin America 101
11.6. The Middle-East 102
11.6.1. Middle East Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 103
11.6.2. Middle East Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 104
11.6.3. Middle East Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 105
11.6.4. Middle East Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 106
11.6.5. Middle East Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 107
11.6.6. GCC Countries 108
11.6.7. Israel 108
11.6.8. Turkey 108
11.6.9. Iran 108
11.6.10. Rest of Middle East & Africa 108
11.7. Africa 109
11.7.1. Africa Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 110
11.7.2. Africa Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 111
11.7.3. Africa Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 112
11.7.4. Africa Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 113
11.7.5. Africa Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 114
11.7.6. South Africa 115
11.7.7. Egypt 115
11.7.8. Nigeria 115
11.7.9. Algeria 115
11.7.10. Morocco 115
11.7.11. Rest of Africa 115

CHAPTER NO. 12 : COMPANY PROFILES 116
12.1. ALK-Abelló A/S 116
12.1.1. Company Overview 116
12.1.2. Product Portfolio 116
12.1.3. Financial Overview 116
12.2. Stallergenes Greer plc 117
12.3. Allergy Therapeutics 117
12.4. HAL Allergy Group 117
12.5. Merck KGaA (Allergopharma) 117
12.6. DBV Technologies 117
12.7. Circassia 117
12.8. Aimmune Therapeutics 117
12.9. Biomay AG 117
12.10. Anergis SA 117
12.11. Torii Pharmaceutical Co., Ltd. 117
12.12. Leti Pharma 117
12.13. Allergon AB 117
12.14. Laboratorios LETI SLU 117

CHAPTER NO. 13 : RESEARCH METHODOLOGY 118
13.1. Research Methodology 118
13.2. Phase I – Secondary Research 119
13.3. Phase II – Data Modeling 119
13.3.1. Company Share Analysis Model 120
13.3.2. Revenue Based Modeling 120
13.4. Phase III – Primary Research 121
13.5. Research Limitations 122
13.5.1. Assumptions 122

List of Figures
FIG NO. 1. Global Allergy Immunotherapy Market Volume & Revenue, 2017 – 2030 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Global Allergy Immunotherapy Market 27
FIG NO. 3. Value Chain Analysis for Global Allergy Immunotherapy Market 28
FIG NO. 4. Market Attractiveness Analysis, By Allergen Type 29
FIG NO. 5. Market Attractiveness Analysis, By Indication 29
FIG NO. 6. Market Attractiveness Analysis, By Treatment 30
FIG NO. 7. Market Attractiveness Analysis, By Distribution Channel 30
FIG NO. 8. Product Life Cycle Analysis 31
FIG NO. 9. Incremental Revenue Growth Opportunity by Allergen Type 32
FIG NO. 10. Incremental Revenue Growth Opportunity by Indication 32
FIG NO. 11. Incremental Revenue Growth Opportunity by Treatment 33
FIG NO. 12. Incremental Revenue Growth Opportunity by Distribution Channel 33
FIG NO. 13. Company Share Analysis, 2020 34
FIG NO. 14. Company Share Analysis, 2022 34
FIG NO. 15. Allergy Immunotherapy Market – Company Volume Market Share, 2022 35
FIG NO. 16. Allergy Immunotherapy Market – Company Revenue Market Share, 2022 36
FIG NO. 17. Market Position of Key Players, 2022 37
FIG NO. 18. Global Allergy Immunotherapy Market Revenue Share, By Allergen Type, 2022 & 2030 40
FIG NO. 19. Global Allergy Immunotherapy Market for Pollen, Volume & Revenue (USD Million) 2017 – 2030 41
FIG NO. 20. Global Allergy Immunotherapy Market for Dust mites, Volume & Revenue (USD Million) 2017 – 2030 42
FIG NO. 21. Global Allergy Immunotherapy Market for Pet dander, Volume & Revenue (USD Million) 2017 – 2030 43
FIG NO. 22. Global Allergy Immunotherapy Market for Mold, Volume & Revenue (USD Million) 2017 – 2030 44
FIG NO. 23. Global Allergy Immunotherapy Market for Others, Volume & Revenue (USD Million) 2017 – 2030 45
FIG NO. 24. Global Allergy Immunotherapy Market Revenue Share, By Indication, 2022 & 2030 47
FIG NO. 25. Global Allergy Immunotherapy Market for Allergic Rhinitis, Volume & Revenue (USD Million) 2017 – 2030 48
FIG NO. 26. Global Allergy Immunotherapy Market for Allergic Asthma, Volume & Revenue (USD Million) 2017 – 2030 49
FIG NO. 27. Global Allergy Immunotherapy Market for Food Allergy, Volume & Revenue (USD Million) 2017 – 2030 50
FIG NO. 28. Global Allergy Immunotherapy Market for Atopic Dermatitis, Volume & Revenue (USD Million) 2017 – 2030 51
FIG NO. 29. Global Allergy Immunotherapy Market for Others, Volume & Revenue (USD Million) 2017 – 2030 52
FIG NO. 30. Global Allergy Immunotherapy Market Revenue Share, By Treatment, 2022 & 2030 54
FIG NO. 31. Global Allergy Immunotherapy Market for Subcutaneous immunotherapy (SCIT), Volume & Revenue (USD Million) 2017 – 2030 55
FIG NO. 32. Global Allergy Immunotherapy Market for Sublingual immunotherapy (SLIT), Volume & Revenue (USD Million) 2017 – 2030 56
FIG NO. 33. Global Allergy Immunotherapy Market for Oral immunotherapy (OIT), Volume & Revenue (USD Million) 2017 – 2030 57
FIG NO. 34. Global Allergy Immunotherapy Market for Treatment 4, Volume & Revenue (USD Million) 2017 – 2030 58
FIG NO. 35. Global Allergy Immunotherapy Market for Treatment 5, Volume & Revenue (USD Million) 2017 – 2030 59
FIG NO. 36. Global Allergy Immunotherapy Market Revenue Share, By Distribution Channel, 2022 & 2030 61
FIG NO. 37. Global Allergy Immunotherapy Market for Hospitals, Volume & Revenue (USD Million) 2017 – 2030 62
FIG NO. 38. Global Allergy Immunotherapy Market for Clinics, Volume & Revenue (USD Million) 2017 – 2030 63
FIG NO. 39. Global Allergy Immunotherapy Market for Pharmacies, Volume & Revenue (USD Million) 2017 – 2030 64
FIG NO. 40. Global Allergy Immunotherapy Market for Distribution Channel 4, Volume & Revenue (USD Million) 2017 – 2030 65
FIG NO. 41. Global Allergy Immunotherapy Market for Distribution Channel 5, Volume & Revenue (USD Million) 2017 – 2030 66
FIG NO. 42. Global Allergy Immunotherapy Market Revenue Share, By Region, 2022 & 2030 68
FIG NO. 43. North America Allergy Immunotherapy Market Volume & Revenue, 2017 – 2022 (USD Million) 74
FIG NO. 44. Europe Allergy Immunotherapy Market Volume & Revenue, 2017 – 2022 (USD Million) 81
FIG NO. 45. Asia Pacific Allergy Immunotherapy Market Volume & Revenue, 2017 – 2022 (USD Million) 88
FIG NO. 46. Latin America Allergy Immunotherapy Market Volume & Revenue, 2017 – 2022 (USD Million) 95
FIG NO. 47. The Middle-East Allergy Immunotherapy Market Volume & Revenue, 2017 – 2022 (USD Million) 102
FIG NO. 48. Africa Allergy Immunotherapy Market Volume & Revenue, 2017 – 2022 (USD Million) 109
FIG NO. 49. Research Methodology – Detailed View 118
FIG NO. 50. Research Methodology 119

List of Tables
TABLE NO. 1. : Global Allergy Immunotherapy Market: Snapshot 20
TABLE NO. 2. : Drivers for the Allergy Immunotherapy Market: Impact Analysis 25
TABLE NO. 3. : Restraints for the Allergy Immunotherapy Market: Impact Analysis 26
TABLE NO. 4. : Global Pollen Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 41
TABLE NO. 5. : Global Pollen Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 41
TABLE NO. 6. : Global Pollen Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 42
TABLE NO. 7. : Global Pollen Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 42
TABLE NO. 8. : Global Pet dander Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 43
TABLE NO. 9. : Global Pet dander Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 43
TABLE NO. 10. : Global Mold Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 44
TABLE NO. 11. : Global Mold Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 44
TABLE NO. 12. : Global Others Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 45
TABLE NO. 13. : Global Others Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 45
TABLE NO. 14. : Global Allergy Immunotherapy for Allergic Rhinitis Market Revenue, By Region, 2017 – 2022 (USD Million) 48
TABLE NO. 15. : Global Allergy Immunotherapy for Allergic Rhinitis Market Revenue, By Region, 2023– 2030 (USD Million) 48
TABLE NO. 16. : Global Allergy Immunotherapy for Allergic Asthma Market Revenue, By Region, 2017 – 2022 (USD Million) 49
TABLE NO. 17. : Global Allergy Immunotherapy for Allergic Asthma Market Revenue, By Region, 2023– 2030 (USD Million) 49
TABLE NO. 18. : Global Allergy Immunotherapy for Food Allergy Market Revenue, By Region, 2017 – 2022 (USD Million) 50
TABLE NO. 19. : Global Allergy Immunotherapy for Food Allergy Market Revenue, By Region, 2023– 2030 (USD Million) 50
TABLE NO. 20. : Global Allergy Immunotherapy for Atopic Dermatitis Market Revenue, By Region, 2017 – 2022 (USD Million) 51
TABLE NO. 21. : Global Allergy Immunotherapy for Atopic Dermatitis Market Revenue, By Region, 2023– 2030 (USD Million) 51
TABLE NO. 22. : Global Allergy Immunotherapy for Others Market Revenue, By Region, 2017 – 2022 (USD Million) 52
TABLE NO. 23. : Global Allergy Immunotherapy for Others Market Revenue, By Region, 2023– 2030 (USD Million) 52
TABLE NO. 24. : Global Subcutaneous immunotherapy (SCIT) Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 55
TABLE NO. 25. : Global Subcutaneous immunotherapy (SCIT) Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 55
TABLE NO. 26. : Global Sublingual immunotherapy (SLIT) Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 56
TABLE NO. 27. : Global Sublingual immunotherapy (SLIT) Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 56
TABLE NO. 28. : Global Oral immunotherapy (OIT) Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 57
TABLE NO. 29. : Global Oral immunotherapy (OIT) Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 57
TABLE NO. 30. : Global Treatment 4 Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 58
TABLE NO. 31. : Global Treatment 4 Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 58
TABLE NO. 32. : Global Treatment 5 Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 59
TABLE NO. 33. : Global Treatment 5 Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 59
TABLE NO. 34. : Global Hospitals Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 62
TABLE NO. 35. : Global Hospitals Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 62
TABLE NO. 36. : Global Clinics Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 63
TABLE NO. 37. : Global Clinics Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 63
TABLE NO. 38. : Global Pharmacies Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 64
TABLE NO. 39. : Global Pharmacies Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 64
TABLE NO. 40. : Global Distribution Channel 4 Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 65
TABLE NO. 41. : Global Distribution Channel 4 Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 65
TABLE NO. 42. : Global Distribution Channel 5 Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 66
TABLE NO. 43. : Global Distribution Channel 5 Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 66
TABLE NO. 44. : Global Allergy Immunotherapy Market Revenue, By Region, 2017 – 2022 (USD Million) 69
TABLE NO. 45. : Global Allergy Immunotherapy Market Revenue, By Region, 2023– 2030 (USD Million) 69
TABLE NO. 46. : Global Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 70
TABLE NO. 47. : Global Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 70
TABLE NO. 48. : Global Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 71
TABLE NO. 49. : Global Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 71
TABLE NO. 50. : Global Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 72
TABLE NO. 51. : Global Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 72
TABLE NO. 52. : Global Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 73
TABLE NO. 53. : Global Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 73
TABLE NO. 54. : North America Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 75
TABLE NO. 55. : North America Allergy Immunotherapy Market Revenue, By Country, 2023– 2030 (USD Million) 75
TABLE NO. 56. : North America Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 76
TABLE NO. 57. : North America Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 76
TABLE NO. 58. : North America Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 77
TABLE NO. 59. : North America Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 77
TABLE NO. 60. : North America Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 78
TABLE NO. 61. : North America Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 78
TABLE NO. 62. : North America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 79
TABLE NO. 63. : North America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 79
TABLE NO. 64. : Europe Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 82
TABLE NO. 65. : Europe Allergy Immunotherapy Market Revenue, By Country, 2023– 2030 (USD Million) 82
TABLE NO. 66. : Europe Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 83
TABLE NO. 67. : Europe Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 83
TABLE NO. 68. : Europe Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 84
TABLE NO. 69. : Europe Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 84
TABLE NO. 70. : Europe Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 85
TABLE NO. 71. : Europe Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 85
TABLE NO. 72. : Europe Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 86
TABLE NO. 73. : Europe Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 86
TABLE NO. 74. : Asia Pacific Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 89
TABLE NO. 75. : Asia Pacific Allergy Immunotherapy Market Revenue, By Country, 2023– 2030 (USD Million) 89
TABLE NO. 76. : Asia Pacific Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 90
TABLE NO. 77. : Asia Pacific Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 90
TABLE NO. 78. : Asia Pacific Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 91
TABLE NO. 79. : Asia Pacific Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 91
TABLE NO. 80. : Asia Pacific Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 92
TABLE NO. 81. : Asia Pacific Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 92
TABLE NO. 82. : Asia Pacific Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 93
TABLE NO. 83. : Asia Pacific Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 93
TABLE NO. 84. : Latin America Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 96
TABLE NO. 85. : Latin America Allergy Immunotherapy Market Revenue, By Country, 2023– 2030 (USD Million) 96
TABLE NO. 86. : Latin America Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 97
TABLE NO. 87. : Latin America Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 97
TABLE NO. 88. : Latin America Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 98
TABLE NO. 89. : Latin America Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 98
TABLE NO. 90. : Latin America Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 99
TABLE NO. 91. : Latin America Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 99
TABLE NO. 92. : Latin America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 100
TABLE NO. 93. : Latin America Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 100
TABLE NO. 94. : Middle East Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 103
TABLE NO. 95. : Middle East Allergy Immunotherapy Market Revenue, By Country, 2023– 2030 (USD Million) 103
TABLE NO. 96. : Middle East Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 104
TABLE NO. 97. : Middle East Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 104
TABLE NO. 98. : Middle East Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 105
TABLE NO. 99. : Middle East Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 105
TABLE NO. 100. : Middle East Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 106
TABLE NO. 101. : Middle East Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 106
TABLE NO. 102. : Middle East Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 107
TABLE NO. 103. : Middle East Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 107
TABLE NO. 104. : Africa Allergy Immunotherapy Market Revenue, By Country, 2017 – 2022 (USD Million) 110
TABLE NO. 105. : Africa Allergy Immunotherapy Market Revenue, By Country, 2023– 2030 (USD Million) 110
TABLE NO. 106. : Africa Allergy Immunotherapy Market Revenue, By Allergen Type, 2017 – 2022 (USD Million) 111
TABLE NO. 107. : Africa Allergy Immunotherapy Market Revenue, By Allergen Type, 2023– 2030 (USD Million) 111
TABLE NO. 108. : Africa Allergy Immunotherapy Market Revenue, By Indication, 2017 – 2022 (USD Million) 112
TABLE NO. 109. : Africa Allergy Immunotherapy Market Revenue, By Indication, 2023– 2030 (USD Million) 112
TABLE NO. 110. : Africa Allergy Immunotherapy Market Revenue, By Treatment, 2017 – 2022 (USD Million) 113
TABLE NO. 111. : Africa Allergy Immunotherapy Market Revenue, By Treatment, 2023– 2030 (USD Million) 113
TABLE NO. 112. : Africa Allergy Immunotherapy Market Revenue, By Distribution Channel, 2017 – 2022 (USD Million) 114
TABLE NO. 113. : Africa Allergy Immunotherapy Market Revenue, By Distribution Channel, 2023– 2030 (USD Million) 114

Frequently Asked Questions:

What is allergy immunotherapy?

Allergy immunotherapy is the name assigned for reducing or, altogether, eliminating allergic reactions to specific allergens through medical treatment. It is also called desensitization or allergy shots. It involves administering gradually increasing doses of the allergen to the patient over a specific time period. What this does is that it allows their immune system to create tolerance and resilience as well as decrease sensitivity to the allergen to minimize its effects.

What are the common types of allergy immunotherapy?

The two main types of allergy immunotherapy are SCIT (Subcutaneous Immunotherapy) and SLIT (Sublingual Immunotherapy). SCIT requires injecting the allergen extract under the skin. On the other hand, SLIT involves placing allergen extracts under the tongue in the form of drops or tablets.

Who can benefit from allergy immunotherapy?

Allergy immunotherapy is usually prescribed for people with moderate to severe allergic reactions. It is recommended particularly to those who have not responded well to medications or allergen avoidance measures. It can be effective for allergic rhinitis, allergic asthma, and insect sting allergies.

How long does allergy immunotherapy treatment typically last?

The duration of allergy immunotherapy treatment varies depending on the individual and their specific allergies. More often than not, the teatment lasts for three to five years. However, some patients may continue treatment for longer periods on the basis of their response and the recommendations of their allergist or immunologist.

What are the potential benefits of allergy immunotherapy?

Allergy immunotherapy offers several benefits, including long-term symptom relief, reduced reliance on medication, prevention of new allergies from developing, and potential improvement in asthma control. What it does is that it significantly enhances the quality of life for individuals suffering from allergies.

Are there any risks or side effects associated with allergy immunotherapy?

It is pretty safe to say that allergy immunotherapy is safe in most cases. But there have been cases and there is always a risk of side effects. Common side effects include local reactions at the injection site, like redness or swelling, and systemic reactions like sneezing, itching, or hives. Severe allergic reactions are rare but can occur. It is important to undergo immunotherapy under the supervision of a qualified healthcare professional.

Is allergy immunotherapy effective for all types of allergies?

Allergy immunotherapy has proved to be most effective for allergies caused by airborne allergens, like pollen, dust mites, and pet dander. It may also be beneficial for insect sting allergies.

How is the allergy immunotherapy market expected to grow in the coming years?

The allergy immunotherapy market is expected to experience steady growth in the coming years. Factors like the rising prevalence of allergies, increasing awareness about immunotherapy as a treatment option, and advancements in allergen extract formulations are driving market growth.

What are some key players in the allergy immunotherapy market?

Quite a number of pharmaceutical companies and research organizations are active in the allergy immunotherapy market. Some prominent players include ALK-Abelló A/S, Stallergenes Greer, Allergy Therapeutics, HAL Allergy Group, and Circassia Pharmaceuticals. These companies develop and manufacture allergen extracts, conduct clinical trials, and provide immunotherapy treatment options

Are there any emerging trends or innovations in the allergy immunotherapy market?

The allergy immunotherapy market is witnessing various trends and innovations. One trend that is pretty noteable is the development of allergen immunotherapy tablets or drops for sublingual administration, providing a convenient and needle-free alternative to injections. What is more is that there is ongoing research in the field of molecular allergology, aiming to identify and target specific allergenic components for more personalized and effective immunotherapy.

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

OTC Cough Cold And Allergy Medicine Market

Published:
Report ID: 20062

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN